Long-term treatment with empagliflozin, a novel, potent and selective SGLT-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats

Diabetes, Obesity and Metabolism

Volumn 14, Issue 1, 2012, Pages 94-96

  Thomas, L ^a   Grempler, R ^a   Eckhardt, M ^a   Himmelsbach, F ^a   Sauer, A ^a   Klein, T ^a   Eickelmann, P ^a   Mark, M ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

BI 10773; Diabetes; Empagliflozin; SGLT; SGLT 2 inhibitor; Type 2 diabetes

Indexed keywords

EMPAGLIFLOZIN; GLUCOSE; HEMOGLOBIN A1C; HYDROXYETHYLCELLULOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; DOSE RESPONSE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE URINE LEVEL; GLYCEMIC CONTROL; HYPERINSULINEMIA; IN VIVO STUDY; INSULIN SENSITIVITY; LONG TERM CARE; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; SINGLE DRUG DOSE; TREATMENT DURATION; ZUCKER DIABETIC FATTY RAT;

EID: 83655167071     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2011.01518.x     Document Type: Article

References (6)

1. Ghosh RK, Ghosh SM, Chawla S, Jasdanwala SA. SGLT2 inhibitors: a new emerging therapeutic class in the treatment of type 2 diabetes mellitus. J Clin Pharmacol 2011 [Epub ahead of print].
2. Bays H. From victim to ally: the kidney as an emerging target for the treatment of diabetes mellitus. Curr Med Res Opin 2009; 25: 671-681.
3. Eickelmann P, Grempler R, Thomas L et al. BI 10773, a novel and selective SGLT-2 inhibitor, lowers blood glucose and improves glycaemic control in diabetic rodent models. Diabetologia 2009; 52: S342-S343.
4. Grempler R, Thomas L, Eckhardt M et al. Empagliflozin, a novel, selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors. Diabetes Obes Metab 2011 [Epub ahead of print].
5. Han S, Hagan DL, Taylor JR et al. Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats. Diabetes 2008; 57: 1723-1729.
6. +)-glucose cotransporter, in neonatally streptozotocin-treated rats. Eur J Pharmacol 2000; 391: 183-192.